Skip to main content Accessibility help
×
×
Home

Effect of Preoperative Antibiotic Prophylaxis on Surgical Site Infections Complicating Cardiac Surgery

  • Renato Finkelstein (a1) (a2), Galit Rabino (a1), Tania Mashiach (a1), Yaron Bar-El (a2) (a3), Zvi Adler (a1), Victor Kertzman (a3), Oved Cohen (a3) and Simcha Milo (a2) (a3)...

Abstract

Objective.

To evaluate the effect of an optimized policy for antibiotic prophylaxis on surgical site infection (SSI) rates in cardiac surgery.

Design.

Prospective cohort study.

Setting.

Tertiary medical center in Israel.

Methods.

SSIs were recorded during a 10-year study period and ascertained through routine surveillance using the National Healthcare Safety Network (NHSN) methodology. Multivariable analyses were conducted to determine which significant covariates, including the administration of preoperative prophylaxis, affected these outcomes.

Results.

A total of 2,637 of 3,170 evaluated patients were included, and the overall SSI rate was 8.4%. A greater than 50% reduction in SSI rates was observed in the last 4 years of the study. Overall and site-specific infection rates were similar for patients receiving cefazolin or vancomycin. SSIs developed in 206 (8.1%) of the 2,536 patients who received preoperative prophylaxis (within 2 hours of the first incision) compared with 14 (13.9%) of 101 patients who received antibiotic prophylaxis at a different time (P = .04; odds ratio [OR], 1.8; 95% confidence interval [CI], 1.0–3.3). After accounting for covariates, preoperative hospital stay (5 days or more), an NHSN risk category (2 or 3), age (60 years or more), surgeon's role, and the period of measurement were significantly associated with SSIs. Emergency surgery, age, surgeon's role, and nonpreoperative prophylaxis were found to be independent predictors of superficial SSI.

Conclusions.

We observed a progressive and significant decrease in SSI rates after the implementation of an infection control program that included an optimized policy of preoperative prophylaxis in cardiac surgery.

Copyright

Corresponding author

Derech Hayam 209/56, 34890 Haifa, Israel (renatof@bezeqint.net)

References

Hide All
1. Mangram, AJ, Horan, TC, Pearson, ML, et al; Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20:247278.
2. Goodman, JS, Schaffner, W, Collins, HA, et al. Infection after cardiovascular surgery. N Engl J Med 1968;278:117123.
3. Fekety, FR, Cluff, LE, Sabiston, DC, et al. A study of antibiotic prophylaxis in cardiac surgery. J Thorac Cardiovasc Surg 1969;57:757763.
4. Fong, IW, Baker, CB, McKee, DC. The value of prophylactic antibiotics in aortic-coronary bypass operations. J Thorac Cardiovasc Surg 1979;78:908913.
5. Austin, TW, Coles, JC, Burnett, R, et al. Aortocoronary bypass procedures and sternotomy infections: a study of antistaphy-lococcal prophylaxis. Can J Surg 1980;23:483485.
6. Burke, JP. Maximizing appropriate surgical antibiotic prophylaxis: an update from LDS hospital. Clin Infect Dis 2001;33(suppl 2):7883.
7. Burke, JP. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961;50:161168.
8. Classen, DC, Evans, RS, Pestotnik, SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281286.
9. Steinberg, JP, Braun, BI, Hellinger, WC, et al; Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) Study Group. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009;250(1):1016.
10. Hawn, MT, Richman, JS, Vick, CC, Deierhoi, RJ, Graham, LA, Henderson, WG, Itani, KM. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg 2013:18.
11. Garner, JS, Jarvis, WR, Emori, TG, et al. CDC definitions of nosocomial infections. In: Olmsted, RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: Mosby, 1996:A1A20.
12. Durack, DT, Lukes, AS, Bright, DK, et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardio-graphic findings. Am J Med 1994;96:200209.
13. National Nosocomial Infections Surveillance [NNIS] report, data summary from October 1996-April 1997, issued May 1997. Am J Infect Control 1997;25:477487.
14. Finkelstein, R, Rabino, G, Mashiah, T, et al. Surgical site infection rates following cardiac surgery: the impact of a 6-year infection control program. Am J Infect Control 2005;33:450454.
15. Finkelstein, R, Rabino, G, Mashiah, T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002;123:326332.
16. McConkey, SJ, L'Ecuyer, PB, Murphy, DM, et al. Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 1999;20:533538.
17. Martorell, C, Engelman, R, Cori, A, et al. Surgical site infections in cardiac surgery: an 11-year perspective. Am J Infect Control 2004;32:6368.
18. Friedman, ND, Bull, AL, Russo, PL, et al. An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2007;28:11621168.
19. Mannien, J, Wille, JC, Kloek, JJ, et al. Surveillance and epidemiology of surgical site infections after cardiothoracic surgery in the Netherlands, 2002-2007. J Thorac Cardiovasc Surg 2011;141:899904.
20. Harrington, G, Russo, P, Spelman, D, et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2004;25:472476.
21. Lepelletier, D, Perron, S, Bizouarn, P, et al. Surgical-site infection after cardiac surgery: incidence, microbiology, and risk factors. Infect Control Hosp Epidemiol 2005;26:466472.
22. Filsoufi, F, Castillo, JG, Rahmanian, PB, et al. Epidemiology of deep sternal wound infection in cardiac surgery. J Cardiothorac Vase Anesth 2009;23:488494.
23. Koch, CG, Nowicki, ER, Rajeswaran, J, Gordon, SM, Sabik, JF, Blackstone, EH. When the timing is right: antibiotic timing and infection after cardiac surgery. J Thorac Cardiovasc Surg 2012;144:931937.
24. Hollenbeak, CS, Murphy, DM, Koenig, S, et al. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000;118:397402.
25. Garey, KW, Dao, T, Chen, H, et al. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother 2006;58:645650.
26. Bratzler, DW, Houck, PM; Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:17061715.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed